Tuesday, February 16, 2021 1:13:17 PM
Eli Lily holds 8.5% through LLV ventures fund.
Novartis owns 10% institutions own 67% of the 40 million shares outstanding.
institutions own 68% of the 40 million shares outstanding.
Potential of 1.2 Billion in total payments from Novartis & GSK with double digit royalties. Also partnered with Merck.
https://www.fiercebiotech.com/biotech/gsk-puts-up-to-815m-table-for-surface-oncology-s-antibody
Surface Oncology (SURF) Explores Potential Sale After GSK Takeover Approach - Source
https://www.streetinsider.com/Hot+M+and+A/Surface+Oncology+%28SURF%29+Explores+Potential+Sale+After+GSK+Takeover+Approach+-+Source/17458243.html
Jim Cramer Surface Oncology Is Set for Further Gains.
https://realmoney.thestreet.com/investing/surface-oncology-is-set-for-further-gains-how-to-buy-it-15542979
http://www.surfaceoncology.com
Golden Chart!
https://stockcharts.com/
$SURF
Recent SURF News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/13/2023 04:15:07 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 09/08/2023 08:10:57 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/08/2023 08:04:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 08:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 08:00:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 08:00:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 08:00:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/08/2023 08:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 01:21:52 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/31/2023 09:18:25 PM
- Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences • GlobeNewswire Inc. • 08/31/2023 08:01:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/30/2023 08:34:27 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/30/2023 08:32:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:31:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2023 12:00:13 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2023 12:00:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2023 12:00:09 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/02/2023 11:06:03 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM